INSIGHTS ON CLINICAL TRIAL DESIGN
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Navigating the Next Wave of CNS Development
Learn how advances in biomarkers, AI, digital endpoints, and translational science can support more informed strategies across CNS drug development.
-
Recruiting & Retaining More Patients Per Site:
Through Home Trial Support (HTS) services, MRN is able to enhance the accessibility of clinical trials while reducing the emotional toll on their patients suffering from loss of mobility.
-
Precision Medicine In Pediatrics: Biomarkers and Assay Development
Discover the rise in FDA-approved pediatric therapies and the role of precision medicine in tailoring treatments to genetic profiles, as well as how biomarkers and assays can enhance pediatric care.
-
Scaling Pharmacovigilance: Clinical Development To Commercialization10/1/2026
Commercial growth brings new PV challenges. Gain practical insights on operating models, technology, governance, and leadership for long-term success.
-
Retention Through Intention — Designing Truly Patient-Centric Trials2/4/2026
High drop-out rates threaten clinical trial integrity. Implementing decentralized solutions and proactive support strategies during protocol design can significantly improve patient enrollment and retention.
-
Navigating Complexity In Master Protocols With Key Operational Partners7/5/2026
Complex adaptive trials offer real efficiency gains, but success hinges on having experienced partners to manage the operational details.
-
Clinical Trial Recruitment Strategies For Rare Disease Studies7/20/2026
By deploying mobile clinics equipped with specialized diagnostic tools and trained technicians, sponsors can execute protocol-adherent assessments right in the participant's community.
-
Navigating The Complex World Of First In Human Oncology Trials5/6/2025
First-in-human oncology trials are critical touchpoints in the development of novel cancer therapies, requiring precise scientific execution and a deeply patient-centric approach.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Explore this suite of multichannel, patient-centered solutions that are powering rapid clinical trial education, engagement, and enrollment.
-
Modernize research pharmacy operations with digital workflows that reduce manual effort, improve compliance, strengthen audit readiness, and help sites support more protocols with confidence.
-
Disconnected vendors mean disconnected data. Discover how a unified supply chain approach helps trial teams reduce risk, save time, and keep drug supply aligned with patient need.
-
CSSi is a global, full-service company offering customized services to support recruitment and retention programs around the world.
-
Clinical trials often require travel coordination, reimbursements, and ongoing logistical support. Explore a service that centralizes those needs to help participants stay engaged.